High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Fiche publication
Date publication
mai 2020
Journal
Intensive care medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr OHANA Mickaël
Tous les auteurs :
Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Anglés-Cano E, Sattler L, Mertes PM, Meziani F,
Lien Pubmed
Résumé
Little evidence of increased thrombotic risk is available in COVID-19 patients. Our purpose was to assess thrombotic risk in severe forms of SARS-CoV-2 infection.
Mots clés
ARDS, COVID-19, Coagulopathy, Lupus anticoagulant, Thrombosis
Référence
Intensive Care Med. 2020 May 4;: